These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32495728)

  • 1. Systematic Review and Evaluation of Mathematical Attack Models of Human Inhalational Anthrax for Supporting Public Health Decision Making and Response.
    Chen X; Bahl P; de Silva C; Heslop D; Doolan C; Lim S; MacIntyre CR
    Prehosp Disaster Med; 2020 Aug; 35(4):412-419. PubMed ID: 32495728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling Tool for Decision Support during Early Days of an Anthrax Event.
    Rainisch G; Meltzer MI; Shadomy S; Bower WA; Hupert N
    Emerg Infect Dis; 2017 Jan; 23(1):46-55. PubMed ID: 27983505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of screening for inhalational anthrax after a bioterrorist attack.
    Hupert N; Bearman GM; Mushlin AI; Callahan MA
    Ann Intern Med; 2003 Sep; 139(5 Pt 1):337-45. PubMed ID: 12965942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public health and bioterrorism: renewed threat of anthrax and smallpox.
    Wallin A; Luksiene Z; Zagminas K; Surkiene G
    Medicina (Kaunas); 2007; 43(4):278-84. PubMed ID: 17485954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical predictors of bioterrorism-related inhalational anthrax.
    Kyriacou DN; Stein AC; Yarnold PR; Courtney DM; Nelson RR; Noskin GA; Handler JA; Frerichs RR
    Lancet; 2004 Jul 31-Aug 6; 364(9432):449-52. PubMed ID: 15288744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhalational anthrax due to bioterrorism: would current Centers for Disease Control and Prevention guidelines have identified the 11 patients with inhalational anthrax from October through November 2001?
    Mayer TA; Morrison A; Bersoff-Matcha S; Druckenbrod G; Murphy C; Howell J; Hanfling D; Cates R; Pauze D; Earls J
    Clin Infect Dis; 2003 May; 36(10):1275-83. PubMed ID: 12746773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anthrax--an overview at 2002].
    Mozes YN; Winder A; Tadmor B; Rotman E; Sagi R; Hourvitz A
    Harefuah; 2002 May; 141 Spec No():63-72, 121, 120. PubMed ID: 12170557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic modeling of emergency events: assessing the impact of hypothetical releases of anthrax.
    Isukapalli SS; Lioy PJ; Georgopoulos PG
    Risk Anal; 2008 Jun; 28(3):723-40. PubMed ID: 18643828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The primary care differential diagnosis of inhalational anthrax.
    Temte JL; Zinkel AR
    Ann Fam Med; 2004; 2(5):438-44. PubMed ID: 15506578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.
    Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA
    Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhalational anthrax.
    Frazier AA; Franks TJ; Galvin JR
    J Thorac Imaging; 2006 Nov; 21(4):252-8. PubMed ID: 17110848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal case of inhalational anthrax mimicking intra-abdominal sepsis.
    Quintiliani R; Quintiliani R
    Conn Med; 2002 May; 66(5):261-7. PubMed ID: 12071107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Historical evolution of human anthrax from occupational disease to potentially global threat as bioweapon.
    D'Amelio E; Gentile B; Lista F; D'Amelio R
    Environ Int; 2015 Dec; 85():133-46. PubMed ID: 26386727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhalational anthrax.
    Cuneo BM
    Respir Care Clin N Am; 2004 Mar; 10(1):75-82. PubMed ID: 15062228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of public health interventions for Anthrax: a report to the secretary's council on Public Health Preparedness.
    Wein LM; Craft DL;
    Biosecur Bioterror; 2005; 3(4):348-56. PubMed ID: 16366844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology and pathogenesis of bioterrorism-related inhalational anthrax.
    Guarner J; Jernigan JA; Shieh WJ; Tatti K; Flannagan LM; Stephens DS; Popovic T; Ashford DA; Perkins BA; Zaki SR;
    Am J Pathol; 2003 Aug; 163(2):701-9. PubMed ID: 12875989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(47):1049-51. PubMed ID: 11808925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid assessment of agents of biological terrorism: defining the differential diagnosis of inhalational anthrax using electronic communication in a practice-based research network.
    Temte JL; Anderson AL
    Ann Fam Med; 2004; 2(5):434-7. PubMed ID: 15506577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When bioterrorism strikes: diagnosis and management of inhalational anthrax.
    Shafazand S
    Semin Respir Infect; 2003 Sep; 18(3):134-45. PubMed ID: 14505276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the logistics of response to anthrax bioterrorism.
    Zaric GS; Bravata DM; Cleophas Holty JE; McDonald KM; Owens DK; Brandeau ML
    Med Decis Making; 2008; 28(3):332-50. PubMed ID: 18349432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.